Financial reports
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 24
8-K
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
6 Mar 24
8-K
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
5 Mar 24
8-K
Regulation FD Disclosure
28 Feb 24
8-K
Other Events
10 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Dec 23
8-K
Departure of Directors or Certain Officers
24 Nov 23
8-K
Results of Operations and Financial Condition
14 Nov 23
8-K
Regulation FD Disclosure
18 Sep 23
8-K
Entry into a Material Definitive Agreement
28 Aug 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
5 Mar 24
25
Voluntary exchange delisting
8 Sep 22
S-8
Registration of securities for employees
2 Sep 22
425
Business combination disclosure
29 Jul 22
425
Business combination disclosure
18 Jul 22
424B3
Prospectus supplement
24 Jun 22
425
Business combination disclosure
21 Jun 22
425
Business combination disclosure
7 Jun 22
S-4
Registration of securities issued in business combination transactions
13 May 22
Proxies
DEFR14A
Revised proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
18 Jul 22
DEFA14A
Additional proxy soliciting materials
18 Jul 22
DEFA14A
Additional proxy soliciting materials
12 Jul 22
DEFM14A
Proxy related to merger
24 Jun 22
DEF 14A
Definitive proxy
30 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Mar 21
Other
EFFECT
Notice of effectiveness
27 Jun 22
CORRESP
Correspondence with SEC
22 Jun 22
UPLOAD
Letter from SEC
23 May 22
EFFECT
Notice of effectiveness
15 Jun 21
CORRESP
Correspondence with SEC
11 Jun 21
UPLOAD
Letter from SEC
10 Jun 21
EFFECT
Notice of effectiveness
29 Apr 21
CORRESP
Correspondence with SEC
27 Apr 21
UPLOAD
Letter from SEC
22 Apr 21
EFFECT
Notice of effectiveness
9 Nov 17
Ownership